TopNewsToday.org
»
»
»

U.S. FDA approves Pfizer/Protalix drug for Gaucher

reuters.com (2 years and 2 months ago)

May 2, 2012

WASHINGTON (Reuters) - U.S. drug regulators gave the nod on Tuesday to Protalix Biotherapeutics Inc and Pfizer Inc's experimental biotech drug for a form of the rare genetic disease Gaucher. full story

More news more news

U.S. FDA approves Pfizer/Protalix drug for Gaucher

reuters.com (2 years and 2 months ago)

FDA approves new drug for Gaucher

foxnews.com (2 years and 2 months ago)

Pfizer Enters Market For Super-Expensive, Ultra-Rare Disease Drugs -- With A Price Cut

forbes.com (2 years and 2 months ago)

Pfizer Enters Market For Super-Expensive, Ultra-Rare Disease Drugs ??? With A Price Cut

forbes.com (2 years and 2 months ago)

Elelyso Approved for Gaucher Disease

yahoo.com (2 years and 2 months ago)

A Sleeper Technology Sector Comes Back to Life

forbes.com (2 years and 2 months ago)

Future of Pfizer: It's the R&D, Stupid!

thestreet.com (2 years and 2 months ago)

Pfizer says on lookout for mid-size drug deals

reuters.com (2 years and 2 months ago)

Pfizer settles lawsuit involving Celebrex

usatoday.com (2 years and 2 months ago)

Summary Box: Charges, generics cut Pfizer 1Q net

yahoo.com (2 years and 2 months ago)

More Health news »

Most read

Most popular

Follow us

Facebook
Twitter
Google+
RSS Feed
US | Sport | Business | Technology | Lifestyle | Entertainment | World | Search
Privacy Policy | About | Contacts
All news and photos belong to their authors.